Health ❯Healthcare ❯Public Health
Public Health Medical Research Medical Treatments Patient Care NHS Cancer Pharmaceuticals Clinical Trials Cancer Treatment Genetics
The five-minute nivolumab jab, approved by the MHRA, will benefit 1,200 patients monthly, replacing IV infusions for 15 cancer types at no additional cost.